Marguerite Koutsoukos

7PUBLICATIONS
72CO-AUTHORS
Innate immunityAnimal protection (incl. pests and pathogens)Agricultural molecular engineering of nucleic acids and proteinsNanotoxicology, health and safetyNanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 20, 2024
Safety and immunogenicity after a 30-month boost of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120/MF59 vaccine boost (HVTN 100): A phase 1-2 randomized double-blind placebo-controlled trial.

Vimla Naicker, Fatima Laher, Linda-Gail Bekker

|Mar 19, 2024
Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial.

Zoe Moodie, Erica Andersen-Nissen, Nicole Grunenberg

|May 26, 2023
Beta-containing bivalent SARS-CoV-2 protein vaccine elicits durable broad neutralization in macaques and protection in hamsters.

Catherine Berry, Vincent Pavot, Natalie G Anosova

|Mar 09, 2023
Beta variant COVID-19 protein booster vaccine elicits durable cross-neutralization against SARS-CoV-2 variants in non-human primates.

Vincent Pavot, Catherine Berry, Michael Kishko

|Apr 01, 2022
Protein-based SARS-CoV-2 spike vaccine booster increases cross-neutralization against SARS-CoV-2 variants of concern in non-human primates.

Vincent Pavot, Catherine Berry, Michael Kishko

|Jul 28, 2021
Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates.

Joseph R Francica, Barbara J Flynn, Kathryn E Foulds

Pageof 2

Frequent Collaborators

4 joint publications

Valerie Lecouturier

4 joint publications

Catherine Berry

3 joint publications

Fatima Laher

3 joint publications

Zoe Moodie